In the setting of early treatment response of HL and anti-PD-1-treatment, both Lugano criteria and LYRIC performed equally with equivocal findings [58], a result that possibly relates to the rather rare occurrence of pseudoprogression in HL [55, 56, 59]. Here, PDCD1 is linked to Hodgkins lymphoma.